Kotha Subbaramaiah

This article (1) has been retracted at the request of the authors based upon evidence of data falsification or fabrication in Figs. 2B, 4C, and 5H. An Editor's Note had previously been issued (2). A copy of this Retraction Notice was sent to the last known e-mail addresses for the 9 authors. Eight authors (Kotha Subbaramaiah, Patrick G. Morris, Xi Kathy Zhou, Monica Morrow, Dilip Giri, Levy Kopelovich, Clifford A. Hudis, and Andrew J.

VOLUME 284 (2009) PAGES 7436–7445 This article has been withdrawn by the authors. The actin immunoblots in Fig. 2, A and B, are the same. Lanes 4 and 6 of the CYP1A1 and CYP1B1 panels in Fig. 3B are the same. Also in Fig. 3B, lanes 2 and 4 of the 18S rRNA panel are the same. The Hsp90 lanes are all the same in Fig. 6F. The control lanes in Fig. 6H were all reused in the control siRNA lanes. Additionally, the TSA lane for Hsp90 in Fig. 6H was reused in the HDAC6 siRNA lane.

VOLUME 283 (2008) PAGES 33955–33968 This article has been withdrawn by the authors. In Fig. 1A, the first two lanes of the 18S rRNA panel were reused in the last two lanes. In Fig. 1D, the last two lanes of the Id-1 panel were reused as 18S rRNA. Also, the first two lanes of the Id-1 panel in Fig. 1D were reused in Fig. 3B. A portion of the actin panel from Fig. 1D was reused in Fig. 4E. In Fig. 1E, lanes 2 and 3 of the 18S rRNA panel are the same.